MFS
XLRN

MSI Financial Services’s Acceleron Pharma XLRN Stock Holding History

MSI Financial Services’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Hold
98
– – ﹤0.01% 3404
2016
Q3 		$4K Hold
98
– – ﹤0.01% 3267
2016
Q2 		$3K Buy
+98
New +$3.19K ﹤0.01% 3416

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

MSI Financial Services's XLRN Position: Q4 2016 in Review

MSI Financial Services held its Acceleron Pharma (XLRN) position steady in Q4 2016 at 98 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3404.

MSI Financial Services first reported a position in XLRN in Q2 2016 and has held it in 3 quarters since. The position peaked at $4K in Q3 2016. 146 funds tracked by Wall St. Rank hold XLRN as of Q4 2016.

  • MSI Financial Services held 98 shares of Acceleron Pharma worth $3K as of Q4 2016.
  • MSI Financial Services left its Acceleron Pharma share count unchanged in Q4 2016.
  • Acceleron Pharma made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3404 holding.
  • MSI Financial Services first reported a position in Acceleron Pharma in Q2 2016 and has held it in 3 quarters since.
  • MSI Financial Services's Acceleron Pharma position peaked at $4K in Q3 2016.
  • 146 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.